rheumatoid arthritis therapy

Astellas Pharma and UCB Have Introduced Cimzia Rheumatoid Arthritis Therapy in Japan
Mar 12, 2013
Astellas Pharma and UCB have introduced Cimzia (certolizumab pegol) rheumatoid arthritis therapy in Japan. The PEGylated Fc-free anti-TNF medication is indicated for adult rheumatoid arthritis patients who showed poor response to ...

Tags: Astellas Pharma, Astellas, rheumatoid arthritis therapy
Astellas Pharma and UCB to Treat Rheumatoid Arthritis in Japan
Dec 27, 2012
Astellas Pharma and UCB have announced the marketing approval of Cimzia (certolizumab pegol) to treat rheumatoid arthritis (RA) in Japan. The Japanese Ministry of Health, Labor and Welfare has approved Cimzia as a 200mg syringe for ...

Tags: Astellas Pharma, UCB, marketing approval, rheumatoid arthritis, RA, Japan
Pfizer Has Won US FDA Approval
Dec 5, 2012
Pfizer has won US FDA approval for its rheumatoid arthritis (RA) therapy, Xeljanz (tofacitinib citrate) 5mg twice daily, indicated for patients who failed to respond to methotrexate. Xeljanz can be used as a single treatment regime or as ...

Tags: Pfizer, tofacitinib citrate, Xeljanz